Key facts
- This page summarizes George Siber's Form 4 filing for GENOCEA BIOSCIENCES, INC..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Jun 2022, 16:11.
George Siber - 27 May 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 27 May 2022
- Net transaction value
- -$1,334
- SEC form
- 4
- Accepted by SEC
- 01 Jun 2022, 16:11:43 UTC
- Prior SEC filing
- 02 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Diantha Duvall, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
George Siber filed Form 4 for GENOCEA BIOSCIENCES, INC. on 01 Jun 2022.
Change
- Previous filing in this sequence was filed on 02 Jul 2021.
- Current net transaction value: -$1,334.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GNCA
transaction
Common Stock
Sale
- Transaction value
- $1,334
- Shares
- -20,425
- Change %
- -99%
- Price
- $0.0653*
- Shares after
- 252
- Date
- 27 May 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.0652 to $0.0657, inclusive.